Showing results (271-280 of 362) with videos related to
Sort By:
Pageof 37
Journal of Cellular Biochemistry|February 4, 2010
Phosphoproteome reveals an atlas of protein signaling networks during osteoblast adhesionRenato Milani, Carmen V Ferreira, José M Granjeiro, et al.Clinical Science (London, England : 1979)|April 14, 2021
In utero and early-life exposure to thirdhand smoke causes profound changes to the immune systemAntoine M Snijders, Mi Zhou, Todd P Whitehead, et al.Cell|April 5, 2011
A rapid and scalable system for studying gene function in mice using conditional RNA interferencePrem K Premsrirut, Lukas E Dow, Sang Yong Kim, et al.Cancer Research|December 6, 2013
CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expressionYunshan Wang, Mingxin Wen, Yongwon Kwon, et al.Journal of Cellular Physiology|June 12, 2008
Internalization and degradation of heparin is not required for stimulus of heparan sulfate proteoglycan synthesisEdvaldo S Trindade, Rodrigo I Bouças, Hugo A O Rocha, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 3, 2021
Cytokine Levels at Birth in Children Who Developed Acute Lymphoblastic LeukemiaTodd P Whitehead, Joseph L Wiemels, Mi Zhou, et al.Cancer Discovery|June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology GroupElliot Stieglitz, Alex G Lee, Steven P Angus, et al.Biochimica Et Biophysica Acta|March 20, 2014
Bauhinia forficata lectin (BfL) induces cell death and inhibits integrin-mediated adhesion on MCF7 human breast cancer cellsMariana C C Silva, Cláudia A A de Paula, Joana G Ferreira, et al.International Journal of Pharmaceutics|June 8, 2024
Systemic delivery of bictegravir and tenofovir alafenamide using dissolving microneedles for HIV preexposure prophylaxisChunyang Zhang, Yu Wu, Aaron R J Hutton, et al.Proceedings of the National Academy of Sciences of the United States of America|March 14, 2014
Crenolanib is a selective type I pan-FLT3 inhibitorCatherine Choy Smith, Elisabeth A Lasater, Kimberly C Lin, et al.Pageof 37